MINI REVIEW
Published on 07 Dec 2021
Human Genetics to Identify Therapeutic Targets for NAFLD: Challenges and Opportunities
doi 10.3389/fendo.2021.777075
- 7,697 views
- 12 citations
- Frontiers in Endocrinology
- Obesity
- Research Topics
- Non-Alcoholic Steatohepatitis (NASH) – Metabolic Contributors and Therapeutic Targets
Non-Alcoholic Steatohepatitis (NASH) – Metabolic Contributors and Therapeutic Targets
95k
Total downloads
274k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 30 Sep 2021
Predictive Modeling of MAFLD Based on Hsp90α and the Therapeutic Application of Teprenone in a Diet-Induced Mouse Model
doi 10.3389/fendo.2021.743202
- 3,757 views
- 10 citations
ORIGINAL RESEARCH
Published on 17 Sep 2021
The Prevalence, Popular Trends, and Associated and Predictive Factors of Non-Obese Fatty Liver Disease
doi 10.3389/fendo.2021.744710
- 2,227 views
- 6 citations
ORIGINAL RESEARCH
Published on 22 Apr 2021
Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population
doi 10.3389/fendo.2021.565714
- 5,891 views
- 12 citations
MINI REVIEW
Published on 09 Apr 2021
Mining Gut Microbiota From Bariatric Surgery for MAFLD
doi 10.3389/fendo.2021.612946
- 4,389 views
- 6 citations
ORIGINAL RESEARCH
Published on 18 Mar 2021
Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine
doi 10.3389/fendo.2021.601160
- 4,659 views
- 23 citations
ORIGINAL RESEARCH
Published on 10 Mar 2021
Dietary Oxysterol, 7-Ketocholesterol Accelerates Hepatic Lipid Accumulation and Macrophage Infiltration in Obese Mice
doi 10.3389/fendo.2020.614692
- 4,706 views
- 16 citations
ORIGINAL RESEARCH
Published on 04 Mar 2021
Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes
doi 10.3389/fendo.2021.642432
- 2,501 views
- 16 citations
REVIEW
Published on 26 Feb 2021
Alternative RNA Splicing in Fatty Liver Disease
doi 10.3389/fendo.2021.613213
- 9,481 views
- 31 citations
SYSTEMATIC REVIEW
Published on 16 Feb 2021
Comparison of the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Patients With Metabolic Associated Fatty Liver Disease: Updated Systematic Review and Meta-Analysis
doi 10.3389/fendo.2020.622589
- 5,326 views
- 25 citations
ORIGINAL RESEARCH
Published on 02 Feb 2021
Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery
doi 10.3389/fendo.2020.611213
- 3,161 views
- 10 citations
REVIEW
Published on 01 Feb 2021
The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease
doi 10.3389/fendo.2020.601627
- 13,878 views
- 83 citations
Published in
Frontiers in Endocrinology
- Obesity
Impact
- 274kTopic views
- 176kArticle views
- 95kArticle downloads